Therapeutic Suppression of Atherosclerotic Burden and Vulnerability via Dll4 Inhibition in Plaque Macrophages Using Dual-Targeted Liposomes
ACS Applied Bio Materials · 2024
DOI: 10.1021/acsabm.4c00923 ↗Kurz gefasst
Fachartikel in der Zeitschrift ACS Applied Bio Materials, 2024. Verfasst von Haixia Du und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiology, Shaanxi Provincial People's Hospital, Xi'an 710068, China. Hauptthemen laut MEDLINE: Liposomes, Macrophages, Particle Size, Plaque, Atherosclerotic. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 27 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Qin Chuang Yuan Traditional Chinese Medicine Innovative Research and Development Project, Youth Research and Innovation Team Project of Shaanxi Province.
Abstract (Originalsprache)
Atherosclerosis, characterized by chronic inflammation within the arterial wall, remains a pivotal concern in cardiovascular health. We developed a dual-targeted liposomal system encapsulating Dll4-targeting siRNA, designed to selectively bind to pro-inflammatory M1 macrophages through surface conjugation with anti-F4/80 and anti-CD68 antibodies. The Dll4-targeting siRNA is then delivered to the macrophages, where it silences Dll4 expression, inhibiting Notch signaling and reducing plaque vulnerability. Emphasizing accuracy in targeting, the system demonstrates effective suppression of Dll4, a key modulator of atherosclerotic progression, and vulnerability via VSMCs phenotypic conversion and senescence. By employing liposomes for siRNA delivery, we observed enhanced stability and specificity of the siRNA. Alongside the therapeutic efficacy, our study also evaluated the safety profile and pharmacokinetics of the dual-targeted liposomal system, revealing favorable outcomes with minimal off-target effects and optimal biodistribution. The integration of RNA interference techniques with advanced nanotechnological methodologies signifies the importance of targeted delivery in this therapeutic approach. Preliminary findings suggest a potential attenuation in plaque development and vulnerability, indicating the therapeutic promise of this approach. This research emphasizes the potential of nanocarrier-mediated precision targeting combined with a reassuring safety and pharmacokinetic profile for advancing atherosclerosis therapeutic strategies.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Cardiology, Shaanxi Provincial People's Hospital, Xi'an 710068, China.
- Department 403, PLA Rocket Force University of Engineering, Xi'an 710025, China.
- Atherosclerosis Integrated Chinese and Western Medicine Key Research Laboratory, Research Office of Shaanxi Administration of Traditional Chinese Medicine, Xi'an 710003, China.
- Traditional Chinese Medicine Inheritance and Innovation Platform, Shaanxi Provincial People's Hospital, Xi'an 710068, China.
- Northwestern Polytechnical University, Affiliated Shaanxi Provincial People's Hospital, Xi'an 710068, China.
- Department of Peripheral Vascular Medicine, The First Affiliated Hospital of Xi'an Jiaotong University, Xi'an 710061, China.
ORCID-Profile: Zhongwei Liu
Förderung
- National Natural Science Foundation of China
- Qin Chuang Yuan Traditional Chinese Medicine Innovative Research and Development Project
- Youth Research and Innovation Team Project of Shaanxi Province
- Shaanxi Provincial Key Research Program
Zitieren
APA
Du, H., Ma, Y., Wang, X., Zhang, J., Zhu, L., Guan, G., Pan, S., Zhang, Y., Wang, J., & Liu, Z. (2024). Therapeutic Suppression of Atherosclerotic Burden and Vulnerability via Dll4 Inhibition in Plaque Macrophages Using Dual-Targeted Liposomes. ACS Applied Bio Materials. https://doi.org/10.1021/acsabm.4c00923
Vancouver
Du H, Ma Y, Wang X, Zhang J, Zhu L, Guan G, et al. Therapeutic Suppression of Atherosclerotic Burden and Vulnerability via Dll4 Inhibition in Plaque Macrophages Using Dual-Targeted Liposomes. ACS Applied Bio Materials. 2024. doi:10.1021/acsabm.4c00923
BibTeX
@article{Du2024,
author = {Du, Haixia and Ma, Yanpeng and Wang, Xiqiang and Zhang, Junbo and Zhu, Ling and Guan, Gongchang and Pan, Shuo and Zhang, Yong and Wang, Junkui and Liu, Zhongwei},
title = {Therapeutic Suppression of Atherosclerotic Burden and Vulnerability via Dll4 Inhibition in Plaque Macrophages Using Dual-Targeted Liposomes},
journal = {ACS Applied Bio Materials},
year = {2024},
doi = {10.1021/acsabm.4c00923}
}
EUVIMED